Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancerChad J. Creighton, Rachel Schiff, Bryan T. Hennessy et al.|Breast Cancer Research|2010Cited by 258
cMET Activation and EGFR-Directed Therapy Resistance in Triple-Negative Breast CancerJoohyuk Sohn, Ana M. González-Angulo|Journal of Cancer|2014Cited by 59
The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast CancerYoung Kwang Chae, Ana M. González-Angulo|PLoS ONE|2016Cited by 17